Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one-year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial.

@article{Nordanstig2014ImprovedQO,
  title={Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one-year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial.},
  author={Joakim Nordanstig and Charles Taft and Marlene Hens{\"a}ter and Angelica Perlander and Klas Osterberg and Lennart Jiveg{\aa}rd},
  journal={Circulation},
  year={2014},
  volume={130 12},
  pages={939-47}
}
BACKGROUND The quality of evidence for invasive revascularization in intermittent claudication is low or very low. This prospective, randomized, controlled study tested the hypothesis that an invasive treatment strategy versus continued noninvasive treatment improves health-related quality of life after 1 year in unselected patients with intermittent claudication. METHODS AND RESULTS After clinical and duplex ultrasound assessment, unselected patients with intermittent claudication requesting… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 11 times over the past 90 days. VIEW TWEETS